Similar articles

• Vide VIDUS.

  Glick N. Glick N. CMAJ. 2003 Aug 5;169(3):187-8; author reply 188. CMAJ. 2003. PMID: 12900468 Free PMC article. No abstract available.
• Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

  Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT. Craib KJ, et al. CMAJ. 2003 Jan 7;168(1):19-24. CMAJ. 2003. PMID: 12515780 Free PMC article.
• [Epidemiological and clinical development of HIV+ patients followed by the Lausanne University Hospital Center from 1982 to 1992].

  Beck C, Chave JP, Glauser MP. Beck C, et al. Rev Med Suisse Romande. 1994 Dec;114(12):1067-74. Rev Med Suisse Romande. 1994. PMID: 7817069 French. No abstract available.
• HIV incidence and prevalence among aboriginal peoples in Canada.

  Duncan KC, Reading C, Borwein AM, Murray MC, Palmer A, Michelow W, Samji H, Lima VD, Montaner JS, Hogg RS. Duncan KC, et al. AIDS Behav. 2011 Jan;15(1):214-27. doi: 10.1007/s10461-010-9792-y. AIDS Behav. 2011. PMID: 20799061 Review.
• Medical management of HIV-hepatitis C virus coinfection in injection drug users.

  Khalsa JH, Kresina T, Sherman K, Vocci F. Khalsa JH, et al. Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S1-6. doi: 10.1086/429488. Clin Infect Dis. 2005. PMID: 16265605 Review.